Cruyssen, B, Van Looy, S, Wyns, B, Westhovens, R, Durez, P, Malaise, M, ...
This study is based on an expanded access program in which 511 patients suffering from active refractory rheumatoid arthritis (RA) were treated with intravenous infusions of infliximab (3 mg/kg+...